Donal Gorman

Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trial

Aditi R. Saxena, Donal Gorman, Ryan M. Esquejo et al. · Nature Medicine · 2021 · 142 citations

Medicine, Endocrinology, Pharmacology +10

Efficacy and Safety of Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist Danuglipron for Glycemic Control Among Patients With Type 2 Diabetes

Aditi R. Saxena, Juan P. Frías, Lisa Brown et al. · JAMA Network Open · 2023 · 132 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Using Multivariable Mendelian Randomization to Disentangle the Causal Effects of Lipid Fractions

Stephen Burgess, Daniel F. Freitag, Hassan Khan et al. · PLoS ONE · 2014 · 103 citations · Full text

Public Health, Biostatistics, Genetics +16

Pharmacology in translation: the preclinical and early clinical profile of the novel α2/3 functionally selective GABA_A receptor positive allosteric modulator PF‐06372865

Sarah A. Nickolls, Rachel Gurrell, Guido van Amerongen et al. · British Journal of Pharmacology · 2017 · 65 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Genome-wide association analysis of pain severity in dysmenorrhea identifies association at chromosome 1p13.2, near the nerve growth factor locus

Amy V. Jones, James R.F. Hockley, Craig Hyde et al. · Pain · 2016 · 59 citations

Life Sciences, Genetics, Molecular Genetics +15